Inventor · disambiguated record
Chi-Ling Tseng
Also filed as: TSENG CHI-LING
7 granted patents·8 pending applications·8 citations·filing 2011–2025
75Inventor score
Top patents by PatentIndex Score
15 records- 0181US11274155B2Anti-PD-L1 antibodies and variantsSHANGHAI HENLIUS BIOTECH INC·Filed 2019·Granted Mar 15, 2022·2 cites·13 claims
- 0281US8771990B2Method of producing lipidated polypeptidesLENG CHIH-HSIANG·Filed 2011·Granted Jul 8, 2014·4 cites·12 claims
- 0370US8658767B2Lipidated polyepitope vaccinesLENG CHIH-HSIANG·Filed 2011·Granted Feb 25, 2014·2 cites·9 claims
- 0466US12447195B2Engineered SIRPα variants and methods of use thereofFBD BIOLOGICS LTD·Filed 2023·Granted Oct 21, 2025·0 cites·4 claims
- 0566US11618786B2Anti-PD-L1 antibodies and variantsSHANGHAI HENLIUS BIOTECH INC·Filed 2022·Granted Apr 4, 2023·0 cites·23 claims
- 0663US11685783B2Anti-PD-1 antibodiesSHANGHAI HENLIUS BIOTECH INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 0763US2025019459A1Anti-msln antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2024·Application pending·0 cites
- 0860US11028173B2Anti-PD-1 antibodiesSHANGHAI HENLIUS BIOTECH INC·Filed 2019·Granted Jun 8, 2021·0 cites·18 claims
- 0960US2023340098A1Anti-garp/tgf-beta antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2023·Application pending·0 cites
- 1055US2023279110A1Anti-cd47 antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2023·Application pending·0 cites
- 1155US2024360219A1Cd47/pd-l1-targeting protein complex and methods of use thereofFBD BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1255US2025051441A1Cd47/4-1bb-targeting protein complex and methods of use thereofFBD BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 1353US2024228584A1Engineered tgfbrii variants and methods of use thereofFBD BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1446US2025288643A1ENGINEERED SIRPá VARIANTS AND METHODS OF USE THEREOFFBD BIOLOGICS LTD·Filed 2025·Application pending·0 cites
- 1535US2018193456A1Anti-vascular endothelial growth factor receptor 2 (vegfr2) antibodiesHENLIUS BIOTECH CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chi-Ling Tseng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →